Key result
Triple valve replacement succeeds in a patient with recurrent post-COVID-19 infective endocarditis and ~19% EuroSCORE II.
Case Report (n=1)
Triple valve replacement can be successfully performed in high-risk patients with recurrent infective endocarditis following COVID-19 infection.
Answers are grounded in this paper and cite their sources.
Supports feasibility of triple valve replacement in high-risk post-COVID endocarditis; leaves open generalizability pending larger studies.
The authors present redo mitral valve replacement, aortic valve and tricuspid valve replacement in a patient with recurrent infective endocarditis following COVID-19 infection. This patient with EuroSCORE II 19.24% underwent successful triple valve replacement. Представлен клинический случай репротезирования митрального, протезирования аортального и трикуспидального клапанов сердца у пациента с рецидивом инфекционного эндокардита после перенесенной инфекции COVID-19. В результате успешного хирургического лечения пациенту с рецидивом инфекционного эндокардита после перенесенной инфекции COVID-19 с риском по шкале EuroSCORE II 19,24% было выполнено протезирование трех клапанов сердца.
No takes yet. Share an insight, caveat, or question.
Podchasov et al. (2025) conducted a case report in Recurrent infective endocarditis following COVID-19 infection (n=1). Triple valve replacement (redo mitral, aortic, and tricuspid) was evaluated on Surgical success. Successful triple valve replacement was performed in a patient with recurrent infective endocarditis following COVID-19 infection and a EuroSCORE II of 19.24%.
Synapse has enriched 10 related papers. Consider them for comparative context: